| Literature DB >> 34422358 |
Abdulhakim Ibrahim1, Elena Marchiori1, Thorsten Eierhoff1, Sven Martens2, Arash Motekallemi2, Andreas Rukosujew2, Alexander Oberhuber1, Giuseppe Asciutto1,3.
Abstract
BACKGROUND: Post-implantation syndrome (PIS) is defined as non-infectious continuous fever and a concomitant rise in inflammatory markers shortly after endovascular aortic repair. PIS occurrence after hybrid procedures, such as the frozen elephant trunk (FET) technique, has not been adequately investigated. The current study aims to define the incidence of PIS after the FET and to identify possible risk factors associated with its occurrence.Entities:
Keywords: Post-implantation syndrome (PIS); aortic thrombus volume; frozen elephant trunk
Year: 2021 PMID: 34422358 PMCID: PMC8339746 DOI: 10.21037/jtd-21-398
Source DB: PubMed Journal: J Thorac Dis ISSN: 2072-1439 Impact factor: 2.895
Figure 1Flow diagram of the inclusion process. PIS, post-implantation syndrome.
Figure 2Exemplary CT displaying curved planar and straight multiplanar reconstruction: (A) centreline in the true lumen has been generated, (B) the area of thrombus has been selective marked and measured separately and manually for each CT slice (marked grey area), (C) the volume of thrombus was measured automatically due to the addition of all CT slices together.
Baseline characteristics of the study population divided according to the presence of PIS
| Variables | Total (n=38) | PIS (n=17) | Non-PIS (n=21) | P value |
|---|---|---|---|---|
| Demographic characteristics | ||||
| Age (years) mean ± SD | 58.5±10.2 | 53.5±8.9 | 62.5±9.6 | 0.005* |
| Female gender, n (%) | 12 (31.5) | 2 (5.2) | 10 (26.3) | 0.018* |
| Type of aortic pathology | ||||
| Acute dissection | 19 (50.0) | 9 (23.7) | 10 (26.3) | |
| Post dissection aneurysm | 10 (26.3) | 7 (18.4) | 3 (7.8) | 0.026* |
| Aneurysm | 9 (23.7) | 1 (2.6) | 8 (21.1) | |
| Max. diameter | 65.7±2.5 | 63.5±4 | 67.4±3.2 | 0.461 |
| Medical history, n (%) | ||||
| Hypertension | 30 (78.9) | 13 (34.2) | 17 (44.7) | 0.541 |
| Previous stroke/TIA | 4 (10.5) | 1 (2.6) | 3 (7.8) | 0.942 |
| COPD | 8 (21.1) | 4 (10.5) | 4 (10.5) | 0.241 |
| Coronary artery disease | 8 (21.1) | 5 (13.1) | 3 (7.8) | 0.832 |
| Chronic heart disease | 3 (7.8) | 2 (5.2) | 1 (2.6) | 0.731 |
| Current/previous smoker | 17 (44.7) | 7 (18.4) | 10 (26.3) | 0.815 |
| Atrial fibrillation | 6 (15.7) | 1 (2.6) | 5 (13.1) | 0.826 |
| Chronic kidney disease | 11 (5.2) | 7 (18.4) | 4 (10.5) | 0.167 |
| Diabetes mellitus | 2 (5.2) | 1 (2.6) | 1 (2.6) | 1 |
| Medication treatment, n (%) | ||||
| ß-Blocker | 21 (55.2) | 10 (26.3) | 11 (28.9) | 0.691 |
| Aspirin | 9 (23.6) | 5 (13.1) | 4 (10.5) | 0.453 |
| Anticoagulation (Heparin) | 7 (55.2) | 3 (26.3) | 4 (28.9) | 1 |
| Statins | 7 (18.4) | 5 (13.1) | 2 (5.2) | 0.112 |
COPD, chronic obstructive pulmonary disease; TIA, transient ischemic attack; SD, standard deviation; *Statistically significant P values.
Baseline characteristics and procedural data
| Variables/Parameters | Total (n=38) | PIS (n=17) | Non-PIS (n=21) | P value |
|---|---|---|---|---|
| Procedure characteristics (mean ± SD) | ||||
| OP duration (hours) | 5.5±1.2 | 5.8±1.6 | 5.3±0.7 | 0.232 |
| ICU stay (days) | 8.9±5.7 | 10±5.9 | 8±5.4 | 0.271 |
| In-hospital Length of stay (days) | 15.5±1.2 | 16.1±4.9 | 15.3±8.1 | 0.717 |
| Length of FET stent graft | 116.2±23.7 | 111.7±21.8 | 120±25.1 | 0.294 |
| Thrombus volume measurement (cm3), median (range) | ||||
| Pre-operative mural thrombus | 10.2 (3–408) | 10 (3–340) | 15 (5.1–408) | 0.078 |
| Post-operative new-onset thrombus | 23 (70–376) | 89.8 (9.5–376) | 3 (0.7–68) | <0.001* |
| New-onset thrombus (cm3), median (range) | ||||
| Acute dissection | 33.2 (10.3–59.4) | 58.5 (23–89.8) | 18.6 (5.4–40.9) | 0.08 |
| Post dissection aneurysm | 110 (49–153.1) | 134 (102.2–211.3) | 20.1 (18–20.1) | 0.02* |
| Platelet count (×1,000/µL), median (IQR) | ||||
| Preoperative | 197 (169–273) | 209 (169–252) | 188 (162–300) | 0.862 |
| 3. Postoperative day | 109 (77–150) | 113 (106–145) | 102 (65–159) | 0.13 |
| 5. Postoperative day | 178 (126–205) | 181 (168–212) | 166 (113–202) | 0.208 |
| 7. Postoperative day | 253 (191–336) | 250 (241–339) | 254 (181–336) | 0.679 |
| Partial Thromboplastin Time (second), median (range) | ||||
| Preoperative | 36.5 (32–38) | 38 (35–40.5) | 35 (32–38) | 0.047* |
| 3. Postoperative day | 42 (36–44) | 43 (38–47) | 40 (34–45) | 0.20 |
| 5. Postoperative day | 38 (34–43) | 41 (37–48) | 38 (29.7–41) | 0.06 |
| 7. Postoperative day | 37 (34–41) | 40 (36–58) | 35 (29–38) | 0.009* |
| International normalized ratio (INR), median (range) | ||||
| Preoperative | 1.1 (1–1.2) | 1.1 (1–1.2) | 1 (1–1.1) | 0.26 |
| 3. Postoperative day | 1.1 (1–1.2) | 1.2 (1.1–1.2) | 1 (0.9–1.2) | 0.08 |
| 5. Postoperative day | 1.1 (1–1.1) | 1.1 (1–1.2) | 1 (1–1.1) | 0.06 |
| 7. Postoperative day | 1.1 (1–1.2) | 1.1 (1–1.3) | 1.1 (1–1.2) | 0.079 |
| Medication treatment, median (range), n (%) | ||||
| Antipyretic (days), median (IQR) | 1 (1.5–4.2) | 3 (1.5–5) | 0.00 (0.00–1) | 0.001* |
| Antibiotic, n (%) | 9 (23.07) | 7 (18.4) | 2 (5.26) | 0.028* |
*, statistically significant P values. ICU, intensive care unit.
Inflammatory markers
| Parameters | Total (n=38) | PIS (n=17) | Non-PIS (n=21) | P value |
|---|---|---|---|---|
| Body temperature | ||||
| Fever | 29 (76.3) | 17 (100.0) | 12 (31.5) | |
| Fever onset (POD) | 0.6±0.58 | 1,2±0.14 | 0.6±0.17 | 0.671 |
| Fever duration, day | 2.5±2.4 | 4.9±0.38 | 0.6±0.17 | 0.007* |
| PCT (ng/mL), median (IQR) | ||||
| 3. Postoperative day | 1.3 (0.4–3.6) | 1.3 (0.4–5.3) | 1.2 (0.3–3.7) | 0.986 |
| 5. Postoperative day | 0.4 (0.1–1) | 0.6 (0.7–1.5) | 0.4 (0.1–0.7) | 0.364 |
| 7. Postoperative day | 0.2 (0.1–0.5) | 0.3 (0.1–1.6) | 0.2 (0.1–0.3) | 0.368 |
*, statistically significant P values. PCT, procalcitonin; IQR, interquartile range.
Figure 3Graphic representation of the median measures of body temperature (A), WBCC (B) and CRP (C) in the PIS and non-PIS group. Middle line (red line) shows the cutoff value of 12.000 WBC (B) and 38 °C temperature (A). *, significant difference between groups (P<0.05); **, high significant difference between groups (P<0.001). PIS, post-implantation syndrome; WBCC, white blood cell count; CRP, C-reactive protein; WBC, white blood cell.
Correlation between the volume of new-onset thrombus and PIS markers
| Parameters | Correlation | Multivariate regression | |||
|---|---|---|---|---|---|
| r | P value | β | P value | ||
| Fever duration, day | 0.618 | <0.001* | 0.263 | 0.168 | |
| CRP (mg/dL), 3. POD | 0.531 | 0.003* | 0.488 | 0.011* | |
| WBCC (×1,000/µL), 5. POD | 0.432 | 0.019* | 0.144 | 0.463 | |
| WBCC (×100/µL), 7. POD | 0.456 | 0.017* | 0.219 | 0.220 | |
*, statistically significant P values. PIS, post-implantation syndrome; CRP, C-reactive protein; WBCC, white blood cell count; POD, postoperative day.
Multivariate analysis
| Variables | Univariable analysis | Multivariate logistic regression | |||||
|---|---|---|---|---|---|---|---|
| OR | 95% CI | P value | OR | 95% CI | P value | ||
| Age (years) | 0.901 | 0831–0.978 | 0.012* | 0.734 | 0.54–0.980 | 0.036* | |
| Volume of new-onset thrombus | 1.056 | 1.015–1.099 | 0.007* | 44.4 | 1.01–1.18 | 0.028* | |
| Femal gender | 0.147 | 0.027–0.808 | 0.027* | 0.61 | 0.01–960 | 0.7 | |
| Type of aortic pathology | 1.358 | 0.631–2.919 | 0.434 | 17 | 0.03–850 | 0.531 | |
| Aneurysm | 0.102 | 0.011–0.920 | 0.042* | ||||
| Acute dissection | 1.23 | 0.344–4.454 | 0.744 | ||||
| Chronic dissection | 4.2 | 0.884–19.94 | 0.71 | ||||
*, statistically significant P values. CI, confidence interval; OR, odds ratio.